Literature DB >> 11180761

Contrast-enhanced computed tomography for diagnosing the intraductal component and small invasive foci of breast cancer.

S Akashi-Tanaka 1, T Fukutomi, K Miyakawa, T Nanasawa, K Matsuo, T Hasegawa, H Tsuda.   

Abstract

It is important to eliminate local residual cancer to avoid local recurrence after breast conserving treatment. Many efforts have been made to detect extensive intraductal components (EICs) and small invasive foci of breast cancer by diagnostic imaging including MRI and contrast-enhanced computed tomography (CE-CT). The abilities and limitations of CE-CT are reviewed in this article. The sensitivity of EIC detection by CE-CT ranges from 76% to 88%, and specificity from 79% to 89%. The sensitivity for detecting EIC and cancerous lesions were significantly higher for CE-CT than for US or MMG. The enhanced patterns of CE-CT demonstrating EIC and small invasive foci were classified into diffuse, spotty, linear and multiple types. The differences of the size of cancerous extension by CE-CT from the pathological EIC were within 2 cm in almost all cases. CE-CT is useful for visualizing EIC and small invasive foci of breast cancer.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11180761     DOI: 10.1007/bf02967473

Source DB:  PubMed          Journal:  Breast Cancer        ISSN: 1340-6868            Impact factor:   4.239


  2 in total

1.  Usefulness of lesion image mapping with multidetector-row helical computed tomography using a dedicated skin marker in breast-conserving surgery.

Authors:  Narumi Harada-Shoji; Takayuki Yamada; Takanori Ishida; Masakazu Amari; Akihiko Suzuki; Takuya Moriya; Noriaki Ohuchi
Journal:  Eur Radiol       Date:  2008-11-15       Impact factor: 5.315

2.  The use of contrast-enhanced computed tomography before neoadjuvant chemotherapy to identify patients likely to be treated safely with breast-conserving surgery.

Authors:  Sadako Akashi-Tanaka; Takashi Fukutomi; Natsuko Sato; Eriko Iwamoto; Toru Watanabe; Noriyuki Katsumata; Masashi Ando; Kunihisa Miyakawa; Tadashi Hasegawa
Journal:  Ann Surg       Date:  2004-02       Impact factor: 12.969

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.